GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis

Am J Hematol. 2021 Mar 1;96(3):E71-E74. doi: 10.1002/ajh.26065. Epub 2020 Dec 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Follow-Up Studies
  • GATA3 Transcription Factor / genetics*
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Hispanic or Latino / genetics
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Polymorphism, Single Nucleotide*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / ethnology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Prognosis
  • Receptors, Cytokine / genetics*
  • Risk Factors
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • CRLF2 protein, human
  • GATA3 Transcription Factor
  • GATA3 protein, human
  • Receptors, Cytokine
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Asparaginase

Supplementary concepts

  • CVAD protocol